Chronic toxicity/oncogenicity study of styrene in CD rats by inhalation exposure for 104 weeks

Toxicological Sciences

Volumn 46, Issue 2, 1998, Pages 266-281

  Cruzan, G ^a   Cushman, J R ^a   Andrews, L S ^a   Granville, G C ^a   Johnson, K A ^a   Hardy, C J ^a   Coombs, D W ^a   Mullins, P A ^a   Brown, W R ^a  

^a ToxWorks   (United States)

Author keywords

CRL CD (Sprague Dawley) rats; Decreased mammary tumors; Decreased pituitary tumors; Inhalation; Nasal irritation; Olfactory epithelium; Oncogenicity; Styrene

Indexed keywords

STYRENE; STYRENE OXIDE;

ADOLESCENT; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; BODY WEIGHT; BREAST ADENOCARCINOMA; CARCINOGENICITY; CHRONIC TOXICITY; CONTROLLED STUDY; EXPOSURE; FEMALE; HISTOPATHOLOGY; HYPOPHYSIS ADENOMA; INHALATION; MALE; NONHUMAN; NOSE IRRITATION; OLFACTORY EPITHELIUM; RAT; SEX DIFFERENCE; SURVIVAL;

ANIMALIA;

EID: 0032416947     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1006/toxs.1998.2533     Document Type: Article

References (43)

1. M.E. Andersen M.L. Gargas J.C. Ramsey Inhalation pharmacokinetics: Evaluating systemic extraction, total in vivo metabolism, and the time course of enzyme induction for inhaled styrene in rats based on arterial blood: Inhaled air ratios Toxicol. Appl. Pharmacol. 73 1984 176 187
2. M.S. Bartlett Properties of sufficiency and statistical tests Proc. R. Soc. Ser. A 160 1937 268 282
3. R.P. Beliles J.H. Butala C.R. Stock S. Makris Chronic toxicity and three-generation reproduction study of styrene monomer in the drinking water of rats Fundam. Appl. Toxicol. 5 1985 855 868
4. T. Coccini C. Fenoglio R. Nano P.D.P. Polver G. Moscato L. Manzo Styrene-induced alterations in the respiratory tract of rats treated by inhalation or intraperitoneally J. Toxicol. Environ. Health 52 1997 63 77
5. D. Coggon Epidemiological studies of styrene-exposed populations Crit. Rev. Toxicol. 24 1994 S107 S116
6. B. Conti C. Maltoni G. Perino A. Gilberti Long-term carcinogenicity bioassays on styrene administered by inhalation, ingestion and injection and styrene oxide administered by ingestion in Sprague–Dawley rats and para-methyl-styrene administered by ingestion in Sprague–Dawley rats and Swiss mice Ann. N.Y. Acad. Sci. 534 1988 203 234
7. G. Cruzan J.R. Cushman L.S. Andrews G.C. Granville R.R. Miller C.J. Hardy D.W. Coombs P.A. Mullins Subchronic inhalation studies of styrene in CD rats and CD-1 mice Fundam. Appl. Toxicol. 35 1997 152 165
8. Gy.A. Csanády A.L. Mendrala R.J. Nolan J.G. Filser A physiologic pharmacokinetic model for styrene and styrene-7,8-oxide in mouse, rat and man Arch. Toxicol. 68 1994 143 157
9. EC Council, 1986, Good Laboratory Practices: EC Council Directive 87/18 EEC of 18 December 1986
10. R.A. Fisher Statistical Methods for Research Workers 1973 Hafner Publishing Co New York p. 96–97
11. Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans; Annex: R. Peto et al., Guidelines for Simple Sensitive Significance Tests for Carcinogenic Effects in Long-Term Animal Experiments 1980 p. 311–426
12. Japan MITI, 1984, Good Laboratory Practices: Japan Ministry of International Trade and Industry, Directive 31 March 1984
13. Jersey, G. C. Balmer, M. F. Quast, J. F. Park, C. N. Scheutz, D. J. Beyer, J. E. Olson, K. J. McCollister, S. B. Rampy, L. W. 1978, Two-Year Chronic Inhalation Toxicity and Carcinogenicity Study on Monomeric Styrene in Rats—Final Report, The Dow Chemical Company, Midland, MI
14. W. Kessler X. Jiang J.G. Filser Direct determination of styrene-7,8-oxide in blood by gas chromatography with flame ionization detection J. Chromatogr. 534 1990 67 75
15. W.H. Kruskal W.A. Wallis Use of ranks on one-criterion variance analysis J. Am. Stat. Assoc. 47 1952 583 621
16. W.H. Kruskal W.A. Wallis J. Am. Stat. Assoc. 48 1953 907 911
17. Maltoni, C. 1978, Letter to International Cooperative Study Group on Long Term Effects of Styrene, 2 October 1978
18. N. Mantel Chi-square test with one degree of freedom: Extensions of the Mantel-Haenszel procedure J. Am. Stat. Assoc. 58 1966 690 700
19. E.E. McConnell J.A. Swenberg Review of styrene and styrene oxide long-term animal studies Crit. Rev. Toxicol. 24 1994 S49 S56
20. McConnell Guides for Toxicologic Pathology. 1992 STP/ARP/AFIP Washington
21. R.R. Miller R. Newhook A. Poole Styrene production, use, and human exposure Crit. Rev. Toxicol. 24 1994 S1 S10
22. T.M. Monticello K. Morgan L. Uriah Nonneoplastic nasal lesions in rats and mice Environm. Health Perspect. 85 1990 249 274
23. National Cancer Institute, 1979a, Bioassay of a Solution of b-Nitrostyrene and Styrene for Possible Carcinogenicity
24. National Cancer Institute, 1979b, Bioassay of Styrene for Possible Carcinogenicity
25. L.M. Odkvist C. Edling H. Hellquist Influence of vapours on the nasal mucosa among industry workers Rhinology 23 1985 121 127
26. OECD, 1982, Good Laboratory Practices in the Testing of Chemicals
27. Y. Ohashi H. Ikeoka H. Koshimo J. Nakata Y. Esaki Degeneration and regeneration of respiratory mucosa of rats after exposure to styrene J. Appl. Toxicol. 6 1986 405 412
28. D.H. Phillips P.B. Farmer Evidence for DNA and protein binding by styrene and styrene oxide Crit. Rev. Toxicol. 24 1994 S35 S46
29. B. Ponomarkov L. Tomatis Effects of long-term oral administration of styrene to mice and rats Scan. J. Work Environ. Health 4 1978 127 135
30. C.S. Rebert T.A. Hall The neuroepidemiology of styrene: A critical review of representative literature Crit. Rev. Toxicol. 24 1994 S57 S106
31. J.H. Roycroft T.J. Mast H.A. Ragan S.L. Grumbein R.A. Miller B.J. Chou Toxicological effects of inhalation exposure to styrene in rats and mice Toxicologist 12 1992
32. D. Scott R.J. Preston A critical review of the cytogenetic effects of styrene with an emphasis on human population monitoring: A synopsis Crit. Rev. Toxicol. 24 1994 S47 S48
33. S.K. Seilkop The effect of body weight on tumor incidence and carcinogenicity testing in B6C3F1 mice and F344 rats Fundam. Appl. Toxicol. 24 1995 247 259
34. S.P. Srivastava M. Das M. Mushtaq Hepatic effects of orally administered styrene in rats J. Appl. Toxicol. 2 1982 219 222
35. S.J. Sumner T.R. Fennell Review of the metabolic fate of styrene Crit. Rev. Toxicol. 24 1994 S11 S34
36. UK HSE, 1989, Good Laboratory Practice, The United Kingdom Compliance Program, Department of Health and Social Security (1986), 1989
37. US EPA, 1989, Good Laboratory Practice: Toxic Substances Control Act Regulations, Title 40 CFR 792, Federal Register 29 November 1983. Amended Federal Register 17 August 1989
38. H. Vainio J. Jarvisalo E. Taskinen Adaptive changes caused by intermittent styrene inhalation on xenobiotic transformation Toxicol. Appl. Pharmacol. 49 1979 7 14
39. M.J. van Zwieten J.A. HogenEsch J.A. Majka G.A. Boorman Nonneoplastic and neoplastic lesions of the mammary gland Pathobiology of the Aging Rat 1994 ILSI Press Washington p. 459–475
40. D.A. Williams A test for differences between treatment means when several dose levels are compared with a zero dose control Biometrics 27 1971 103 117
41. D.A. Williams The comparison of several dose levels with a zero dose control Biometrics 28 1972 519 531
42. J.R. Withey P.G. Collins The distribution and pharmacokinetics of styrene monomer in rats by the pulmonary route J. Environ. Pathol. Toxicol. 2 1979 1329 1342
43. J.T. Young Histologic examination of the rat nasal cavity Fundam. Appl. Toxicol. 1 1981 309 312